? PROTEOMICS AND METABOLOMICS SHARED RESOURCE The DCI Proteomics and Metabolomics Shared Resource (DPM) provides the wide variety of mass spectrometry-based untargeted (?omic) and targeted qualitative and quantitative capabilities for proteomics and for targeted metabolomics which are needed to support basic science studies. The lab also has the scale needed for support of clinical research studies, including biomarker discovery and biomarker verification experiments. The DPM is equipped with seven high-resolution mass spectrometers, three triple-quadrupole mass spectrometers, and eleven Ultra Performance Liquid Chromatography (UPLC) systems. This equipment includes four state-of-the-art mass spectrometers purchased within the past 18 months ? a Fusion Lumos Tribrid with Electron Transform Dissociation (Thermo), Fusion Lumos Tribrid with Electron Transform Dissociation and UV Photodissociation (Thermo), a Q Exactive HF-X (Thermo) and a TQ-XS (Waters). The DPM has a full-time staff of eleven scientists, including six PhDs (four Research Professors, one scientific staff member and one Post- Doc). This group has over 195 years? combined experience in mass spectrometry and more than 379 authored or co-authored publications (counting publications with two DMP members as co-authors as two author- publications). The resource is located in a new (2017) ~8,100 sq. ft. laboratory in the Chesterfield Building in downtown Durham, custom built for mass spectrometry-based proteomics and metabolomics. By working closely with vendors to obtain extensive discounts, prudent use of DPM Betterments Funds towards the new equipment, and the DCI CCSG support, the DPM has maintained cost-effective (revenue neutral) support for the DCI at state-of-the-art levels. The DPM?s objective is to generate high-quality data by providing full service to its customers. This includes initial consultations to create optimal experimental designs, use of rigorous QC protocols and standards from sample preparation through sample analyses, and generation of detailed reports to ensure clarity on experimental approach and results. Use of a Laboratory Information Management System (LIMS) ensures sample integrity (unique Project Numbers and Sample IS numbers automatically assigned by the LIMS), and the use of a true ?fingerprinted? data repository (?GCB Express Data Repository?) ensures data integrity. In 2018, the DPM provided services to 95 DCI members (41% of unique users), who accounted for 17% of total usage and represented 7 of the 8 DCI Research Programs. Use of this shared resource by DCI Members contributed to 65 publications over the project period, 19 of which were in high impact journals (IF>9), demonstrating the value of services offered by the resource. During this time, the DPM received support from the DCI CCSG and Institutional Support from the SoM in the form of new lab costs (design and build of new facility in the Chesterfield building) and new instrumentation (three state-of-the-art mass spectrometers). R: 2019 Competing Renewal Shared Resources Proteomics and Metabolomics FINAL Documents P&M Abstract Final Review 1.14.19.docx

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014236-47
Application #
10118135
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-01
Project End
2024-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
47
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Wu, Mengxi; Huang, Po-Hsun; Zhang, Rui et al. (2018) Circulating Tumor Cell Phenotyping via High-Throughput Acoustic Separation. Small 14:e1801131
Vlahovic, Gordana; Meadows, Kellen L; Hatch, Ace J et al. (2018) A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. Oncologist 23:782-790
Xu, Yinghui; Liu, Hongliang; Liu, Shun et al. (2018) Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer. Int J Cancer 143:2400-2408
Feng, Yun; Wang, Yanru; Liu, Hongliang et al. (2018) Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer. Mol Carcinog 57:216-224
Naqvi, Ibtehaj; Gunaratne, Ruwan; McDade, Jessica E et al. (2018) Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. Mol Ther 26:1020-1031
Wen, Juyi; Liu, Hongliang; Wang, Lili et al. (2018) Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy. J Thorac Oncol 13:660-675
Li, Bo; Wang, Yanru; Xu, Yinghui et al. (2018) Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. Int J Cancer 142:2303-2312
Gearhart-Serna, Larisa M; Jayasundara, Nishad; Tacam Jr, Moises et al. (2018) Assessing Cancer Risk Associated with Aquatic Polycyclic Aromatic Hydrocarbon Pollution Reveals Dietary Routes of Exposure and Vulnerable Populations. J Environ Public Health 2018:5610462
Bakthavatsalam, Subha; Sleeper, Mark L; Dharani, Azim et al. (2018) Leveraging ?-Glutamyl Transferase To Direct Cytotoxicity of Copper Dithiocarbamates against Prostate Cancer Cells. Angew Chem Int Ed Engl 57:12780-12784
Dai, Ziwei; Mentch, Samantha J; Gao, Xia et al. (2018) Methionine metabolism influences genomic architecture and gene expression through H3K4me3 peak width. Nat Commun 9:1955

Showing the most recent 10 out of 513 publications